Steffen Pietzke
2016 - PDL BioPharma
In 2016, Steffen Pietzke earned a total compensation of $627.7K as Controller and Chief Accounting Officer at PDL BioPharma, a 74% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,652 |
|---|---|
| Salary | $267,800 |
| Stock Awards | $100,254 |
| Other | $40,000 |
| Total | $627,706 |
Pietzke received $267.8K in salary, accounting for 43% of the total pay in 2016.
Pietzke also received $219.7K in non-equity incentive plan, $100.3K in stock awards and $40K in other compensation.
Rankings
In 2016, Steffen Pietzke's compensation ranked 10,365th out of 14,075 executives tracked by ExecPay. In other words, Pietzke earned more than 26.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,365 out of 14,075 | 26th |
Division Manufacturing | 4,004 out of 5,486 | 27th |
Major group Chemicals And Allied Products | 1,412 out of 1,900 | 26th |
Industry group Drugs | 1,131 out of 1,543 | 27th |
Industry Biological Products, Except Diagnostic Substances | 199 out of 287 | 31st |
Source: SEC filing on April 28, 2017.
Pietzke's colleagues
We found four more compensation records of executives who worked with Steffen Pietzke at PDL BioPharma in 2016.